CORE LABORATORIES INC (CLB) Fundamental Analysis & Valuation
NYSE:CLB • US21867A1051
Current stock price
16.74 USD
+0.41 (+2.51%)
Last:
This CLB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CLB Profitability Analysis
1.1 Basic Checks
- CLB had positive earnings in the past year.
- In the past year CLB had a positive cash flow from operations.
- CLB had positive earnings in each of the past 5 years.
- In the past 5 years CLB always reported a positive cash flow from operatings.
1.2 Ratios
- With a decent Return On Assets value of 5.08%, CLB is doing good in the industry, outperforming 72.58% of the companies in the same industry.
- The Return On Equity of CLB (11.15%) is better than 75.81% of its industry peers.
- CLB has a Return On Invested Capital of 8.43%. This is in the better half of the industry: CLB outperforms 74.19% of its industry peers.
- CLB had an Average Return On Invested Capital over the past 3 years of 8.27%. This is below the industry average of 13.21%.
- The last Return On Invested Capital (8.43%) for CLB is above the 3 year average (8.27%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.08% | ||
| ROE | 11.15% | ||
| ROIC | 8.43% |
ROA(3y)5.57%
ROA(5y)4.69%
ROE(3y)13.4%
ROE(5y)12.68%
ROIC(3y)8.27%
ROIC(5y)7.43%
1.3 Margins
- CLB has a better Profit Margin (5.63%) than 66.13% of its industry peers.
- CLB's Profit Margin has improved in the last couple of years.
- CLB has a Operating Margin of 11.27%. This is in the better half of the industry: CLB outperforms 61.29% of its industry peers.
- CLB's Operating Margin has declined in the last couple of years.
- Looking at the Gross Margin, with a value of 20.69%, CLB is doing worse than 64.52% of the companies in the same industry.
- In the last couple of years the Gross Margin of CLB has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.27% | ||
| PM (TTM) | 5.63% | ||
| GM | 20.69% |
OM growth 3Y7.86%
OM growth 5Y-1.65%
PM growth 3Y12.27%
PM growth 5YN/A
GM growth 3Y1.78%
GM growth 5Y-2.17%
2. CLB Health Analysis
2.1 Basic Checks
- CLB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- The number of shares outstanding for CLB has been reduced compared to 1 year ago.
- CLB has more shares outstanding than it did 5 years ago.
- CLB has a better debt/assets ratio than last year.
2.2 Solvency
- CLB has an Altman-Z score of 3.29. This indicates that CLB is financially healthy and has little risk of bankruptcy at the moment.
- CLB's Altman-Z score of 3.29 is fine compared to the rest of the industry. CLB outperforms 75.81% of its industry peers.
- CLB has a debt to FCF ratio of 4.91. This is a neutral value as CLB would need 4.91 years to pay back of all of its debts.
- With a Debt to FCF ratio value of 4.91, CLB perfoms like the industry average, outperforming 53.23% of the companies in the same industry.
- A Debt/Equity ratio of 0.41 indicates that CLB is not too dependend on debt financing.
- CLB has a Debt to Equity ratio (0.41) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.41 | ||
| Debt/FCF | 4.91 | ||
| Altman-Z | 3.29 |
ROIC/WACC1.01
WACC8.33%
2.3 Liquidity
- CLB has a Current Ratio of 2.02. This indicates that CLB is financially healthy and has no problem in meeting its short term obligations.
- CLB has a Current ratio of 2.02. This is comparable to the rest of the industry: CLB outperforms 56.45% of its industry peers.
- A Quick Ratio of 1.51 indicates that CLB should not have too much problems paying its short term obligations.
- With a Quick ratio value of 1.51, CLB perfoms like the industry average, outperforming 58.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.51 |
3. CLB Growth Analysis
3.1 Past
- The earnings per share for CLB have decreased strongly by -13.64% in the last year.
- Measured over the past years, CLB shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.77% on average per year.
- CLB shows a small growth in Revenue. In the last year, the Revenue has grown by 0.51%.
- Measured over the past years, CLB shows a small growth in Revenue. The Revenue has been growing by 1.56% on average per year.
EPS 1Y (TTM)-13.64%
EPS 3Y9.43%
EPS 5Y-0.77%
EPS Q2Q%-4.55%
Revenue 1Y (TTM)0.51%
Revenue growth 3Y2.45%
Revenue growth 5Y1.56%
Sales Q2Q%6.98%
3.2 Future
- The Earnings Per Share is expected to grow by 20.48% on average over the next years. This is a very strong growth
- Based on estimates for the next years, CLB will show a small growth in Revenue. The Revenue will grow by 4.46% on average per year.
EPS Next Y1.89%
EPS Next 2Y-3.21%
EPS Next 3Y21.51%
EPS Next 5Y20.48%
Revenue Next Year0.19%
Revenue Next 2Y2.44%
Revenue Next 3Y5.49%
Revenue Next 5Y4.46%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. CLB Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 22.03, the valuation of CLB can be described as rather expensive.
- CLB's Price/Earnings ratio is a bit cheaper when compared to the industry. CLB is cheaper than 77.42% of the companies in the same industry.
- When comparing the Price/Earnings ratio of CLB to the average of the S&P500 Index (27.95), we can say CLB is valued slightly cheaper.
- A Price/Forward Earnings ratio of 21.62 indicates a rather expensive valuation of CLB.
- Based on the Price/Forward Earnings ratio, CLB is valued a bit cheaper than 62.90% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of CLB to the average of the S&P500 Index (38.68), we can say CLB is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.03 | ||
| Fwd PE | 21.62 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, CLB is valued a bit more expensive than 66.13% of the companies in the same industry.
- CLB's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.35 | ||
| EV/EBITDA | 11.34 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- CLB has a very decent profitability rating, which may justify a higher PE ratio.
- CLB's earnings are expected to grow with 21.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)11.68
PEG (5Y)N/A
EPS Next 2Y-3.21%
EPS Next 3Y21.51%
5. CLB Dividend Analysis
5.1 Amount
- CLB has a yearly dividend return of 0.24%, which is pretty low.
- Compared to an average industry Dividend Yield of 0.99, CLB has a dividend in line with its industry peers.
- With a Dividend Yield of 0.24, CLB pays less dividend than the S&P500 average, which is at 1.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.24% |
5.2 History
- The dividend of CLB decreases each year by -32.09%.
- CLB has paid a dividend for at least 10 years, which is a reliable track record.
- CLB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-32.09%
Div Incr Years0
Div Non Decr Years4
5.3 Sustainability
- 6.30% of the earnings are spent on dividend by CLB. This is a low number and sustainable payout ratio.
DP6.3%
EPS Next 2Y-3.21%
EPS Next 3Y21.51%
CLB Fundamentals: All Metrics, Ratios and Statistics
NYSE:CLB (4/21/2026, 11:52:20 AM)
16.74
+0.41 (+2.51%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)02-04 2026-02-04/amc
Earnings (Next)04-29 2026-04-29/amc
Inst Owners111.17%
Inst Owner Change-0.07%
Ins Owners1.28%
Ins Owner Change9.71%
Market Cap770.88M
Revenue(TTM)526.52M
Net Income(TTM)29.67M
Analysts48
Price Target16.49 (-1.49%)
Short Float %10.13%
Short Ratio11.31
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.24% |
Yearly Dividend0.04
Dividend Growth(5Y)-32.09%
DP6.3%
Div Incr Years0
Div Non Decr Years4
Ex-Date02-13 2026-02-13 (0.01)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.53%
Min EPS beat(2)10.2%
Max EPS beat(2)12.86%
EPS beat(4)2
Avg EPS beat(4)4.52%
Min EPS beat(4)-4.67%
Max EPS beat(4)12.86%
EPS beat(8)5
Avg EPS beat(8)6.38%
EPS beat(12)7
Avg EPS beat(12)5.91%
EPS beat(16)9
Avg EPS beat(16)4.12%
Revenue beat(2)2
Avg Revenue beat(2)2.93%
Min Revenue beat(2)1.44%
Max Revenue beat(2)4.41%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)4.41%
Revenue beat(8)4
Avg Revenue beat(8)0.13%
Revenue beat(12)5
Avg Revenue beat(12)-0.57%
Revenue beat(16)5
Avg Revenue beat(16)-0.87%
PT rev (1m)2.11%
PT rev (3m)2.11%
EPS NQ rev (1m)-21.5%
EPS NQ rev (3m)-22.06%
EPS NY rev (1m)2.67%
EPS NY rev (3m)2.67%
Revenue NQ rev (1m)-2.62%
Revenue NQ rev (3m)-2.62%
Revenue NY rev (1m)0.8%
Revenue NY rev (3m)0.8%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.03 | ||
| Fwd PE | 21.62 | ||
| P/S | 1.46 | ||
| P/FCF | 34.35 | ||
| P/OCF | 20.82 | ||
| P/B | 2.9 | ||
| P/tB | 5.04 | ||
| EV/EBITDA | 11.34 |
EPS(TTM)0.76
EY4.54%
EPS(NY)0.77
Fwd EY4.63%
FCF(TTM)0.49
FCFY2.91%
OCF(TTM)0.8
OCFY4.8%
SpS11.43
BVpS5.78
TBVpS3.32
PEG (NY)11.68
PEG (5Y)N/A
Graham Number9.93831 (-40.63%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.08% | ||
| ROE | 11.15% | ||
| ROCE | 12.42% | ||
| ROIC | 8.43% | ||
| ROICexc | 8.86% | ||
| ROICexgc | 11.78% | ||
| OM | 11.27% | ||
| PM (TTM) | 5.63% | ||
| GM | 20.69% | ||
| FCFM | 4.26% |
ROA(3y)5.57%
ROA(5y)4.69%
ROE(3y)13.4%
ROE(5y)12.68%
ROIC(3y)8.27%
ROIC(5y)7.43%
ROICexc(3y)8.61%
ROICexc(5y)7.72%
ROICexgc(3y)11.22%
ROICexgc(5y)10.05%
ROCE(3y)12.17%
ROCE(5y)10.94%
ROICexgc growth 3Y11.64%
ROICexgc growth 5Y0.73%
ROICexc growth 3Y10.88%
ROICexc growth 5Y0.32%
OM growth 3Y7.86%
OM growth 5Y-1.65%
PM growth 3Y12.27%
PM growth 5YN/A
GM growth 3Y1.78%
GM growth 5Y-2.17%
F-Score7
Asset Turnover0.9
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.41 | ||
| Debt/FCF | 4.91 | ||
| Debt/EBITDA | 1.49 | ||
| Cap/Depr | 99.59% | ||
| Cap/Sales | 2.77% | ||
| Interest Coverage | 7.25 | ||
| Cash Conversion | 50.03% | ||
| Profit Quality | 75.64% | ||
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.51 | ||
| Altman-Z | 3.29 |
F-Score7
WACC8.33%
ROIC/WACC1.01
Cap/Depr(3y)84.58%
Cap/Depr(5y)77.2%
Cap/Sales(3y)2.44%
Cap/Sales(5y)2.46%
Profit Quality(3y)84.16%
Profit Quality(5y)89.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.64%
EPS 3Y9.43%
EPS 5Y-0.77%
EPS Q2Q%-4.55%
EPS Next Y1.89%
EPS Next 2Y-3.21%
EPS Next 3Y21.51%
EPS Next 5Y20.48%
Revenue 1Y (TTM)0.51%
Revenue growth 3Y2.45%
Revenue growth 5Y1.56%
Sales Q2Q%6.98%
Revenue Next Year0.19%
Revenue Next 2Y2.44%
Revenue Next 3Y5.49%
Revenue Next 5Y4.46%
EBIT growth 1Y-2.31%
EBIT growth 3Y10.5%
EBIT growth 5Y-0.11%
EBIT Next Year20.74%
EBIT Next 3Y31.2%
EBIT Next 5Y23.36%
FCF growth 1Y-48.24%
FCF growth 3Y14.89%
FCF growth 5Y-13.37%
OCF growth 1Y-34.33%
OCF growth 3Y13.99%
OCF growth 5Y-8.55%
CORE LABORATORIES INC / CLB Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for CORE LABORATORIES INC?
ChartMill assigns a fundamental rating of 5 / 10 to CLB.
What is the valuation status of CORE LABORATORIES INC (CLB) stock?
ChartMill assigns a valuation rating of 4 / 10 to CORE LABORATORIES INC (CLB). This can be considered as Fairly Valued.
What is the profitability of CLB stock?
CORE LABORATORIES INC (CLB) has a profitability rating of 6 / 10.
What are the PE and PB ratios of CORE LABORATORIES INC (CLB) stock?
The Price/Earnings (PE) ratio for CORE LABORATORIES INC (CLB) is 22.03 and the Price/Book (PB) ratio is 2.9.
Is the dividend of CORE LABORATORIES INC sustainable?
The dividend rating of CORE LABORATORIES INC (CLB) is 3 / 10 and the dividend payout ratio is 6.3%.